PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 22 filers reported holding PHARVARIS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,616,000 | -63.7% | 450,251 | 0.0% | 0.07% | -66.7% |
Q2 2022 | $9,951,000 | +75.8% | 450,251 | +48.8% | 0.21% | +139.3% |
Q1 2022 | $5,659,000 | +46.0% | 302,619 | +23.6% | 0.09% | +78.0% |
Q4 2021 | $3,875,000 | -8.3% | 244,925 | 0.0% | 0.05% | -10.7% |
Q3 2021 | $4,225,000 | -57.1% | 244,925 | -54.8% | 0.06% | -57.6% |
Q2 2021 | $9,840,000 | -29.9% | 541,563 | +8.3% | 0.13% | -36.5% |
Q1 2021 | $14,030,000 | – | 500,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 3,743,450 | $78,125,802 | 43.39% |
venBio Partners LLC | 4,264,672 | $89,003,705 | 25.24% |
Bain Capital Life Sciences Investors, LLC | 4,784,674 | $99,856,146 | 11.17% |
5AM Venture Management, LLC | 587,600 | $12,263,212 | 3.53% |
VR Adviser, LLC | 1,563,513 | $32,630,516 | 3.44% |
Novo Holdings A/S | 1,329,325 | $27,743,013 | 2.05% |
Cormorant Asset Management, LP | 1,361,460 | $28,413,670 | 1.66% |
GENERAL ATLANTIC, L.P. | 4,406,252 | $91,958,479 | 1.42% |
Foresite Capital Management V, LLC | 33,142 | $691,674 | 1.10% |
Soleus Capital Management, L.P. | 343,975 | $7,178,758 | 0.66% |